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Listeria monocytogenes Virulence
M. HERLER,1 A. BUBERT,1† M. GOETZ,1 Y. VEGA,2 J. A. VAZQUEZ-BOLAND,2 AND W. GOEBEL1*
Biocenter of the University of Wu¨rzburg (Microbiology), Wu¨rzburg, Germany,1 and Molecular Bacterial Pathogenesis
Group, Veterinary Faculty, Complutense University, 28040 Madrid, Spain2
Received 24 April 2001/Accepted 9 July 2001
Transcription factor PrfA controls the expression of virulence genes essential for Listeria monocytogenes
pathogenesis. To gain insight into the structure-function relationship of PrfA, we devised a positive-selection
system to isolate mutations reducing or abolishing transcriptional activity. The system is based on the
observation that the listerial iap gene, encoding the p60 protein, is lethal if overexpressed in Bacillus subtilis.
A plasmid in which the iap gene is placed under the control of the PrfA-dependent hly promoter was
constructed and introduced into B. subtilis. This strain was rapidly killed when expression of iap was induced
by introduction of a second plasmid carrying prfA. Two classes of B. subtilis survivor mutants were identified:
one carried mutations in iap, and the second carried mutations in prfA. Sequence analysis of the defective prfA
genes identified mutations in three regions of the PrfA protein: region A, between amino acids 58 and 67 in the
b-roll domain of PrfA; region B, between amino acids 169 and 193, which corresponds to the DNA-binding
helix-turn-helix motif; and region C, comprising the 38 C-terminal amino acids of PrfA, which form a leucine
zipper-like structure. PrfA proteins with mutations in regions B and C were unable to bind to the PrfA-binding
site in the target DNA, while mutations in region A resulted in a protein still binding the target DNA but unable
to form a stable complex with RNA polymerase and initiate transcription in vitro.
The PrfA protein controls the expression of a regulon com-
prising essential virulence genes required by facultative intra-
cellular pathogen Listeria monocytogenes to colonize its verte-
brate hosts (17, 26, 31, 51). The occurrence of the prfA gene is
not restricted to food-borne human pathogen L. monocyto-
genes (15, 17, 33); it is also present in animal pathogen Listeria
ivanovii (32). In these two pathogenic Listeria species the prfA
gene is part of a chromosomal island clustering several viru-
lence genes, all regulated by PrfA, including prfA itself (25, 50).
Recent studies have shown that other virulence-associated
genes located outside of this gene cluster (including especially
internalin [inl] genes) are also regulated by PrfA (12, 13, 14, 34,
37, 41, 43).
PrfA belongs to the large cyclic AMP (cAMP) receptor
protein (CRP)/Fnr family of bacterial transcription factors,
which are predominantly found in gram-negative bacteria. The
amino acid sequence of PrfA shows substantial similarity to
that of CRP of Escherichia coli (31), a key mediator of catab-
olite repression in conjunction with activator cofactor cAMP
(8, 23). Recent studies indicate that structural conservation
between CRP and PrfA is also functionally relevant, as de-
duced from mutational analysis of the helix-turn-helix domain
interacting with DNA (46). Also, mutations in amino acids
known to lead to cAMP-independent, constitutively active
CRP proteins lead in the listerial regulator to PrfA protein
forms which strongly activate PrfA-dependent expression in
vivo (42) and which bind more strongly to PrfA-binding sites in
vitro than wild-type PrfA (52). cAMP is not known to be
produced by gram-positive bacteria, and thus it is not surpris-
ing that the cAMP-binding site of CRP is not well conserved in
PrfA (52). There are, however, interesting differences between
these two regulatory proteins, such as a second putative helix-
turn-helix motif from amino acids 7 to 30 present in PrfA but
absent in CRP and especially the additional 30-amino-acid C
terminus of PrfA, which shows a leucine zipper-like motif (31).
To approach the structure-function analysis of PrfA, we
developed a positive-selection system for the isolation of mu-
tant PrfA proteins with reduced or lost activity. In our selection
procedure, we used the listerial iap gene, encoding the exten-
sively studied p60 protein, one of the major secreted proteins
and a major protective antigen of L. monocytogenes (6, 22, 38).
This protein possesses peptidoglycan hydrolase activity but
seems to enhance also the uptake of L. monocytogenes by
mammalian host cells (19, 27) especially by fibroblasts (28).
Proteins related to p60 of L. monocytogenes were also found in
all other listerial species (7). They all contain peptidoglycan
hydrolase activity but differ from the L. monocytogenes p60
protein by the absence of a repeat sequence which is exclu-
sively found in the central part of the L. monocytogenes protein
(7) and which may be involved in the above-described en-
hanced internalization of L. monocytogenes. The isolated p60
protein lyses gram-positive bacteria including Bacillus subtilis,
and the p60-like protein of Listeria grayi seems to exert the
most efficient lytic activity on B. subtilis. In contrast to that of
most virulence genes of L. monocytogenes, the expression of
the iap gene is independent of PrfA (48) and appears to occur
constitutively under all conditions studied (53).
* Corresponding author. Mailing address: Biocenter of the Univer-
sity of Wu¨rzburg (Microbiology), Wu¨rzburg, Germany. Phone: 49 931
8884401. Fax: 49 931 8884402. E-mail: goebel@biozentrum.uni
-wuerzburg.de.
† Present address: Scientific Laboratories Products, Merck KGaA,
Darmstadt, Germany.
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We reasoned that overexpression of the iap gene in B. sub-
tilis by a PrfA-dependent promoter in the presence of PrfA
would kill the bacteria unless either the iap gene or the prfA
gene was inactivated by mutations in functionally important
domains of the two encoded proteins, p60 and PrfA. In this
paper we show that this approach is feasible and leads to the
expected mutant proteins. We present data on the prfA mutant
alleles we generated with this strategy; these alleles encode a
variety of PrfA2 protein variants affected in obviously impor-
tant functional domains of the listerial virulence gene regula-
tor.
MATERIALS AND METHODS
Bacterial strains and culture conditions. L. monocytogenes serovar 1/2a EGD
was obtained from S. H. E. Kaufmann (Max-Planck-Institut fu¨r Infektionsbiolo-
gie, Berlin, Germany). Construction of the isogenic prfA deletion mutant has
been described previously (47). The L. monocytogenes rough mutant RIII is
derived from a smooth strain of serovar 1/2a (39) and was obtained from J. Potel
(Institute for Medical Academy, Hannover, Germany). L. grayi was obtained
from the Special Listeria Culture Collection (Institute for Hygiene and Micro-
biology, University of Wu¨rzburg, Wu¨rzburg, Germany). B. subtilis DB104 (hisH
nprR2 nprE18 DaprE) was derived from R. Doi (University of California, Davis,
Davis). This strain carries lesions in the structural genes for extracellular neutral
(nprE) and serine (aprA) proteases (21). Plasmid pUC18 (57) was used for
cloning experiments with E. coli JM109. Construction and use of plasmid shuttle
vector pERL3502 carrying an erythromycin resistance gene and the prfA and
plcA genes of L. monocytogenes have been previously described (33, 48). Plasmid
pLSV 18 consists of gram-positive plasmid pBC16-1 (24), carrying a tetracycline
resistance gene, and pUC18. Further details about its construction are given in
Fig. 1.
Media and reagents. L. monocytogenes and B. subtilis strains were grown in
brain heart infusion (BHI) broth (Difco Laboratories, Detroit, Mich.). E. coli
strains were cultured in Luria-Bertani media. Erythromycin (5 mg/ml for Listeria
or Bacillus strains; 300 mg/ml for E. coli strains), 7.5 mg of tetracycline/ml, or 50
mg of ampicillin/ml (E. coli) was added to broth or agar when required. Elec-
troporation and protoplast transformation methods were used as previously
described (55, 56). DNA-modifying enzymes were purchased from Roche
(Mannheim, Germany), Pharmacia (Uppsala, Sweden), and Eurogentec (Brus-
sels, Belgium). [g-32P]ATP (3,000 Ci/mmol) was purchased from Amersham
(Braunschweig, Germany).
Amplification procedures, DNA manipulations, and DNA sequencing. For
amplification of the iap gene under the control of the Phly promoter, primer pairs
59-ATGTCGAATTCCATGGTCATCGTATCATGTGTACCTG-39 (EcoRI) and
59-TCATGGGTTACCCTCTCCTTCTAC-39 (BstEII), amplifying the Phly re-
gion, and 59-GAGAGGGTTACCATGAATATGAAAAAAGCAACGATC
G-39 (BstEII) and 59-AAGTGAATTCTTATACGCGACCGAAGCCAA-39
(EcoRI), for the iap open reading frame, were used. For cloning experiments,
restriction sites (underlined; the associated restriction endonucleases are in pa-
rentheses) were introduced into the primers. The amplification of DNA se-
quences by PCR was performed in a 100-ml reaction volume in accordance with
protocols by Innis et al. (20). DNA sequencing was performed with the T7
sequencing kit (Pharmacia) and various internal primers from the known iap and
hly gene sequences.
The procedures for isolation of plasmid DNA from E. coli and for recombi-
nant DNA techniques were according to standard protocols (45).
Isolation of plasmid DNA from B. subtilis and L. monocytogenes was per-
formed using the Nucleobond kit (Macherey-Nagel). The manufacturer‘s proto-
col was modified by incubation of the bacteria in buffer S1 with 10 mg of
lysozyme/ml for 5 min at 37°C.
For PCR amplifications, chromosomal DNA of L. monocytogenes was ob-
tained by incubating bacteria in 13 PCR buffer (Eurogentec) containing 2.4 mg
of lysozyme (Sigma, St. Louis, Mo.)/ml for 15 min at 37°C and then incubating
them for 15 min at 56°C with proteinase K (final concentration, 0.24 mg/ml;
Sigma). The lysis procedure was completed by incubating bacteria for 5 min at
110°C and transferring them immediately on ice. For PCR, 1 to 2 ml from this
crude lysate was used.
Preparation of the anti-L. grayi p60 antiserum. To generate an antiserum
specific for the L. grayi p60, synthetic peptide KQLNKLDSDRIVPG (positions
54 to 67 from the N terminus) was derived from the known amino acid sequence
(7). The peptide was produced as a multiple-antigen peptide immobilized via a
lysine branch to a polyethylene glycol resin (10) in a peptide sequencer (Applied
Biosystems, Foster City, Calif.) with 9-fluorenylmethoxy carbonyl chemistry (49).
By using this type of peptide immobilization, no subsequent coupling to a carrier
protein is necessary. A New Zealand White rabbit (Charles River, Kisslegg,
Germany) was subcutaneously injected with 750 mg of the peptide emulsified in
oil adjuvant for primary immunization, boosted three times with 750 mg of the
peptide, also emulsified in oil adjuvant, on days 14, 21, and 28, and then bled
after 38 days (18). The serum was stored in aliquots at 220°C. The anti-PrfA
antiserum, generated by immunization of a guinea pig with a recombinant PrfA
carrying a histidine tag, was described recently (2). Preparation of the rabbit
anti-L. monocytogenes p60 antiserum has been described earlier (22).
Protein preparations, SDS-PAGE, and immunoblotting. Supernatant proteins
were precipitated with trichloroacetic acid (7% [vol/vol]), washed with acetone,
and solubilized in Laemmli sample buffer (22, 30). Total cellular proteins from
FIG. 1. Construction of the Listeria-E. coli shuttle vector pLSV18
carrying iap(G) under the control of the hly promoter, Phly. The DNA
sequences of all primers used for amplification of cloned fragments are
given in Materials and Methods.
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2 ml of a Bacillus or Listeria culture grown to logarithmic phase were obtained by
incubating bacteria for 15 min at 37°C in 20 ml of TE buffer (10 mM Tris-HCl,
1 mM EDTA; pH 8.0) containing 20 mg of lysozyme (Sigma)/ml. After 5 ml of
fivefold-concentrated Laemmli sample buffer was added, bacteria were heated
for 5 min at 95°C. Nucleic acids were then degraded by incubating the samples
for 10 min at 37°C in the presence of 11 U of Benzonase (Sigma). All samples
were heated at 95°C for 5 min before electrophoresis.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with
12.5% polyacrylamide gels was used for protein separations as previously de-
scribed (30). For immunoblotting, proteins were transferred from SDS-polyacryl-
amide gels by semidry electrotransfer (29). Nitrocellulose filters were blocked
and incubated in either anti-p60(M) (L. monocytogenes) (22) or anti-p60(G) (L.
grayi) or anti-PrfA antiserum and horseradish peroxidase-conjugated anti-rabbit
or anti-guinea pig immunoglobulins (DAKO, Hamburg, Germany). The blot was
developed with 4-chloro-1-naphthol (0.5 mg/ml) and hydrogen peroxide
(0.025%). All comparative immunoblotting was performed three times.
Purification of overexpressed His-tagged proteins. The mutant prfA genes
were cloned into pQE30 expression vectors (Qiagen, Hilden, Germany). The
six-His-tagged PrfA proteins were purified by chromatography by Ni-nitrilotri-
acetic acid affinity chromatography (Qiagen) as previously described (2). Protein
purity was analyzed by Coomassie staining of SDS-polyacrylamide gels as de-
scribed by Laemmli (30).
EMSA. Electrophoretic mobility shift assays (EMSA) with protein extracts
were performed as described by Bo¨ckmann et al. (2). EMSA with the purified
mutant PrfA proteins were performed with the 109-bp DNA probe of the hly
promoter region as described previously (11). For CI complex formation, par-
tially purified RNA polymerase (RNAP) from L. monocytogenes, cultivated in
BHI medium and shifted to minimal medium for 30 min (RNAPMEM) (M.
Lalic-Muelthaler, J. Bohne, and W. Goebel, submitted for publication), was
added to the binding assay mixtures containing PrfA bound to the DNA. These
were further incubated for 5 min at 37°C and 10 min on ice.
Runoff in vitro transcription assays. In vitro transcription was performed in
runoff experiments as previously described (1; Lalic-Muelthaler et al., submitted)
using the probe of the plcA promoter region (1), resulting in a 109-base transcript
and the same RNAP as that described above (see “EMSA”).
RESULTS
Overexpression of iap(G) under the control of the hly pro-
moter in B. subtilis is lethal in the presence of functional PrfA.
Plasmid pLSV18 was constructed as shown in Fig. 1. It carries
the iap gene of L. grayi, iap(G), under the control of the L.
monocytogenes PrfA-dependent hly promoter, Phly, instead of
the L. monocytogenes iap gene, iap(M), since previous studies
have shown that p60(G), the product of the iap(G) gene, ex-
hibits the highest bacteriolytic activity of all listerial p60 pro-
teins (A. Bubert, unpublished data).
To test whether induced expression of iap(G) in the pres-
ence of PrfA may be lethal for B. subtilis, we transformed B.
subtilis DB104 (21) with pLSV18 and pERL3502. The latter
plasmid carries the prfA gene under the control of PrfA-spe-
cific promoters P1 and P2 and the PrfA-dependent plcA pro-
moter (16), resulting in efficient synthesis of PrfA (5). In the
transformation protocol we first introduced pLSV18 into
DB104 and monitored the expression of p60(G) with an anti-
serum which was raised against a p60(G)-specific peptide (7).
As shown in Fig. 2A, this antiserum specifically recognized
p60(G) in the supernatant of L. grayi. When the supernatant of
B. subtilis DB104(pLSV18) transformants were analyzed, only
small amounts of p60(G) were detected (Fig. 2A, lane d4),
suggesting that expression of Phly-iap(G) in B. subtilis is very
low in the absence of PrfA.
DB104(pLSV18) was then transformed with pERL3502.
The expected double transformants were selected on agar
plates containing tetracycline (pLSV18 carries a tetracycline
resistance gene) and erythromycin (resistance to this antibiotic
is carried by pERL3502). Only a few colonies were repeatedly
obtained in these transformation assays (about 10 per assay,
while more than 104 transformants were routinely obtained
when pERL3502 or pLSV18 was separately transformed into
DB104). The resistance to both antibiotics suggested the pres-
ence of both plasmids in these transformants.
We next analyzed the presence of p60(G) in the culture
supernatants of these transformants with p60(G) antiserum.
Based on the amount of produced p60(G), the obtained trans-
formants fell into three different groups: group I transformants
did not produce any detectable p60(G), group II transformants
secreted amounts of p60(G) as small as that secreted by the B.
subtilis strain without pERL3502, and group III transformants
secreted large amounts of p60(G). Further analysis of the
iap(G) and prfA genes by PCR with iap- or prfA-specific prim-
ers revealed that group I transformants carried an intact prfA
gene but that the iap(G) gene was deleted. Group III trans-
formants carried an intact prfA gene, which led to the observed
induced production of p60(G), but the p60(G) proteins pro-
duced were functionally inactive, as revealed by a previously
described chain disruption assay using L. monocytogenes mu-
tant RIII (5, 22) (data not shown).
Group II transformants, which did not produce large
amounts of p60 (Fig. 2B), were tested for the presence of PrfA
by immunoblotting with anti-PrfA antiserum. Some of these
group II transformants did not produce any PrfA, and PCR
analysis revealed the complete loss of the prfA gene in these
transformants. Other transformants of this group synthesized
PrfA proteins whose sizes were the same as or smaller than
that of the wild-type PrfA protein (Fig. 2C). These PrfA pro-
teins were apparently strongly impaired in their ability to ac-
tivate expression of Phly-iap(G), suggesting that they carried
mutations causing the loss or reduction of their transcriptional
activity.
Sequence analysis of the prfA genes of group II transfor-
mants. We sequenced all prfA genes of type II transformants
that showed normal-size prfA-specific PCR products and some
prfA genes of reduced size. Figure 3 summarizes the results of
this sequence analysis. As expected, all prfA genes which
yielded PCR products with normal sizes carried either mis-
sense or nonsense point mutations, leading to PrfA proteins
with single amino acid exchanges or to shorter PrfA products.
Two of the mutant prfA genes carried in-frame deletions lead-
ing to PrfA products which had lost three amino acids. Inter-
estingly, most of the missense point mutations were clustered
in three regions of the prfA gene, corresponding to amino acids
58 to 67 (region A), 169 to 193 (region B), and the C-terminal
38 amino acids (region C). In the last region we observed an
interesting mutation resulting in loss of most of the C-terminal
extension of PrfA, which is missing in the related CRP of E.
coli. This last deletion and some of the described missense
mutations (especially mutation R188I) were obtained several
times in independent mutagenesis experiments with B. subtilis,
suggesting that our collection of prfA mutations probably in-
cludes some affecting amino acid positions critical for PrfA
function. This procedure will not identify mutations in the
promoter(s) responsible for the expression of prfA in
pERL3502 since these would result in the loss of prfA tran-
scription.
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Binding of mutant PrfA proteins to the PrfA-binding site of
the hly/plcA promoter region. To test whether the loss of or
reduction in transcriptional activation of the PrfA-dependent
hly promoter by the mutant PrfA proteins observed in B. sub-
tilis is caused by an impaired capacity to bind to the target
DNA sequence (the PrfA box) or to other factors required for
transcription initiation of PrfA-dependent genes (2, 11, 40), we
prepared bacterial extracts of the B. subtilis transformants car-
rying these mutant prfA genes. These bacterial extracts were
tested by EMSA using a P32-labeled DNA fragment carrying
the PrfA box shared by the hly and plcA genes. As shown in Fig.
4A, extracts containing mutant PrfA proteins were either un-
able to form a CI complex (RNAP plus PrfA bound to the
promoter [11]) with this DNA fragment (Q21*, DELK101-103,
D133Y, K139T, R188I, L193*, DFYV207-209, and A218*) or
showed strongly reduced CI formation (M58I, Y62C, and
Y83S). Extracts of a prfA-deleted L. monocytogenes strain ex-
pressing the last three mutant PrfA proteins also showed re-
duced CI formation (Fig. 4B), while this L. monocytogenes
strain, carrying the other prfA mutants, did not yield any CI
complex (data not shown).
We further studied the functional defect in these PrfA mu-
tants using purified proteins. For this analysis we selected mu-
tants M58I (region A), R188I (region B), and A218* (region
C) (Fig. 3). As shown previously (2), PrfA tagged with six His’s
at the N terminus retains full activity in vitro and in vivo. The
binding of these proteins to the hly promoter region was as-
sessed by an EMSA as described before using a double-
stranded oligonucleotide carrying the PrfA box and the 210
motif (35).
As shown in Fig. 5A, the wild-type PrfA protein led to the
formation of the CIII complex in a dose-dependent fashion, as
previously described (11). The PrfA protein with a mutation in
region A (mutant M58I) also yielded a CIII complex, albeit at
a reduced efficiency (about 60% compared to that for the
wild-type PrfA protein). In contrast, the PrfA proteins with
mutations in region B and C did not yield CIII complexes or
yielded them in very small amounts.
The minor band migrating at a position similar to that for
the CIII complex, seen in the shift experiments with PrfA
mutant proteins R188I and A218*, seems to derive mainly
from the oligonucleotide probe as this band is present in a
similar concentration in the control lane (C), which contains
the same amount of the radioactively labeled oligonucleotide
FIG. 2. Specific recognition of p60(G) with anti-L. grayi p60 antiserum and determination of extracellular p60(G) produced by group II
transformants of B. subtilis carrying pLSV18 and pERL3205. (A) Immunoblotting of culture supernatant proteins (1 ml) was performed with
p60(G) antiserum (a), L. monocytogenes p60 antiserum (b), or a cocktail of both antisera (same dilutions) (c). Lanes: 1, supernatant of L. grayi;
2, supernatant of L. monocytogenes EGD. (d) Supernatants of B. subtilis DB104 (lane 3) and B. subtilis carrying pLSV18 and pERL3502 (lane 4).
Proteins from supernatants (2 ml) were separated by SDS-PAGE and immunostained with the anti-p60 antisera (1:400 dilution). (B) Supernatant
from the p60(G) protein of group II transformants of B. subtilis carrying pLSV18 and pERL3502. Immunoblotting of proteins from culture
supernatants (2 ml) was performed with anti-p60(G) antiserum (1:400 dilution). As controls equal volumes of supernatant from L. grayi and B.
subtilis pLSV18* and pERL3502 were used. pLSV18* produces an inactive p60 protein. (C) PrfA protein of the same transformants of B. subtilis
carrying pLSV18 and pERL3502. Immunoblotting of bacterial lysates, separated by SDS-PAGE, was performed with PrfA antiserum (1:500
dilution). Controls are lysates from L. monocytogenes EGD (positive) and B. subtilis pLSV18* without pERL3502 (negative). The data shown are
derived from differently developed immunoblots of various gel runs, which explains the different intensities of the PrfA protein bands.
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used in the shift experiments but no PrfA protein. The band
migrating below the CIII complex in the EMSA with wild-type
PrfA is of unknown nature but is often observed at higher PrfA
concentrations and may represent a complex of monomeric
PrfA bound to the oligonucleotide probe.
The data suggest that the region A PrfA mutant protein
retained the capacity to bind to its target DNA while the PrfA
proteins with mutations in regions B and C lost this binding
capacity.
Previous studies have shown that the CIII complex is shifted
to the CI complex by adding protein extract from a prfA dele-
tion mutant (11) or partially purified listerial RNAP. This shift
was readily obtained in the control with wild-type PrfA (Fig.
5B), whereas with PrfA from mutant M58I mainly the CII
complex (RNAP bound to the promoter [11]) and little CI
complex (about 5 to 10% of the amount of CII complex ob-
served with the wild-type PrfA) was obtained. This inability of
M58I to shift complex CIII to CI is not due to a reduced
amount of CIII complex as the levels of CIII complexes for the
wild-type PrfA and the M58I mutant PrfA proteins are similar
(Fig. 5B). These results suggest that mutant M58I PrfA protein
can still interact with its target site but is strongly impaired in
its ability to bind RNAP. As expected no CI complex formation
was observed with PrfA mutant proteins R188I and A218*
(Fig. 5B).
Activity of the PrfA2 mutant protein in an in vitro tran-
scription assay. The lack of CI complex formation also sug-
gested that the three mutant PrfA proteins may not be able to
initiate transcription starting at PrfA-dependent promoters.
This was directly tested in a recently developed in vitro tran-
scription assay using partially purified RNAP (1; Lalic-
Muelthaler et al., submitted). For the runoff assay we applied
a DNA template which initiates transcription at the PrfA-
dependent plcA promoter (PplcA) and RNAP from L. monocy-
togenes (RNAPMEM) cultivated in BHI medium and shifted
into minimal medium for 30 min (Lalic-Muelthaler et al., sub-
mitted). As shown in Fig. 6, transcription starting from PplcA
was obtained in the presence of the wild-type PrfA protein but
not with the mutant PrfA proteins (R188I and A218*). Tran-
scriptional activation of the mutant M58I is strongly reduced
compared to that of the wild-type PrfA protein (about 5%
residual activity with 20 ng of mutant PrfA protein), which is in
accord with the reduction in CI complex formation shown in
Fig. 5B.
FIG. 3. Amino acid exchanges in the mutant PrfA proteins obtained from the group II transformants of B. subtilis DB104 carrying pLSV18
and pERL3502. Upper lane, amino acid sequence encoded by wild-type prfA; the amino acids below indicate the altered positions in the various
group II mutants. HTH, helix-turn-helix motif; arrowheads, putative leucine zipper motifs; asterisk, stop codon; -, deleted amino acids. Each
marked amino acid alteration belongs to an individual mutant.
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DISCUSSION
We report here the identification of mutant proteins which
are impaired in the transcriptional activation of PrfA by taking
advantage of a system which selects for mutations in the prfA
gene that lead to the loss or reduction in the activity of the L.
monocytogenes virulence gene regulator. The system is based
on the strong bacteriolytic activity of the p60 protein of L. grayi
for B. subtilis (5). The p60 protein of L. monocytogenes and the
p60-related proteins produced by all listerial species (7) pos-
sess peptidoglycan hydrolase activity, which appears to act in a
late step of cell wall synthesis of Listeria and which is prefer-
entially secreted into the supernatant during the stationary
phase (44, 55). In recent studies it has been shown (A. Bubert,
unpublished data) that p60(G) exerts the highest lytic activity
on B. subtilis and other gram-positive bacteria, while B. subtilis
is able to tolerate a significantly higher concentration of the L.
monocytogenes p60 (55). The iap gene of L. grayi encoding the
p60(G) protein is not expressed in B. subtilis when put under
the control of the promoter of the PrfA-dependent listeriolysin
gene (hly) of L. monocytogenes in the absence of functional
PrfA. However, introduction of the prfA gene activates this
promoter and leads only to the production of p60(G), which
kills most bacilli. Under these conditions, B. subtilis survives if
mutations have inactivated either the iap or the prfA gene.
Such mutants are obtained at a frequency of about 1028 after
transformation of B. subtilis with plasmid pERL3502, which
carries the prfA gene under the control of the PrfA-dependent
plcA promoter, leading to efficient synthesis of PrfA (35).
With this selection system we have obtained two classes of
mutations; in one class iap deletion or point mutations within
the iap gene apparently eliminated or inactivated the p60 pro-
tein, while in the second class mutations within prfA led to the
inactivation of essential functions of the PrfA protein. Some of
the prfA point mutations generate stop codons leading to
rather short PrfA peptides, but most others represent missense
mutations leading to the synthesis of mutant PrfA proteins
with single amino acid exchanges. The latter mutations and
also some of the shorter in-frame deletions are clustered in
three regions of PrfA, designated A, B, and C.
Mutations in region B affect the helix-turn-helix domain of
PrfA, which is highly homologous to the corresponding DNA
binding domain of the related regulatory CRP of E. coli (31).
Recent studies (46) have indeed shown that this PrfA domain
is responsible for the interaction of PrfA with its specific bind-
ing site, i.e., the PrfA box, a sequence of dyad symmetry com-
prising 14 nucleotides (16, 36). Within PrfA region B, the
R188I exchange was obtained six times in independent mu-
tagenesis experiments, suggesting that this amino acid position
is very critical for the function of the helix-turn-helix domain.
Not surprisingly, this amino acid exchange in PrfA leads to a
mutant protein which is strongly impaired in its ability to bind
to the PrfA box of Phly/PplcA, used as specific PrfA target site in
our binding assays.
More interesting are the mutations in prfA affecting the
C-terminal part of PrfA or region C. This 38-amino-acid C-
terminal sequence of PrfA exhibits a leucine zipper-like motif
and is missing in the related CRP and other regulatory proteins
belonging to the CRP/Fnr family of regulatory proteins (31).
Two of these mutant PrfA proteins, one of which carries a
3-amino-acid deletion in this region of PrfA while the other
has lost the last 17 amino acids, were further analyzed. Both
mutants, similar to region B mutants, are completely unable to
bind to the PrfA box. Preliminary results indicate that these
mutant PrfA proteins are unable to dimerize, at least under in
vitro conditions, suggesting that the leucine zipper-like domain
of this sequence may be involved in the dimerization of PrfA,
as already shown for other proteins carrying similar leucine
zipper domains (31). Nevertheless, our results do not exclude
the possibility that the loss of this C-terminal region alters the
overall conformation of the PrfA protein, thus prohibiting the
proper folding of the helix-turn-helix DNA binding domain.
Region A of PrfA is located between amino acids 58 and 67.
The corresponding region in CRP represents a potential acti-
vator loop that might directly contact RNAP (54). It has been
FIG. 4. (A) EMSA with a 32P-labeled hly promoter DNA fragment and protein extracts of B. subtilis DB104 transformants carrying the various
mutated prfA genes (see Fig. 3). As controls protein extracts of L. monocytogenes EGD (C1), L. monocytogenes prfA mutant D42 (C2), and B.
subtilis DB104 carrying pERL3502 (BS) were used. (B) EMSA with protein extracts from L. monocytogenes D42 with mutant PrfA proteins M58I,
Y62C, and Y83S. CI and CII, complexes of target DNA with PrfA and RNAP (CI) or with target DNA and RNAP alone (CII) (11).
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shown that this loop may be involved in transcriptional activa-
tion of class II promoters by CRP; such promoters carry the
CRP binding site at position 242 (8, 9, 23), i.e., similar to the
position of the PrfA box in PrfA-dependent listerial promoters.
In contrast to the mutant PrfA proteins of the other two
classes, purified PrfA protein from region A mutants binds to
the PrfA box of the hly/plcA promoter region with an efficiency
of about 60% of that of wild-type PrfA. These data suggest that
the binding of this mutant PrfA protein to its DNA target site
is essentially intact. However, the binding of this PrfA protein
to its specific target site does not permit the subsequent asso-
ciation of RNAP with this complex, which readily occurs with
the wild-type PrfA protein. In addition, in vitro transcription
starting from the PrfA-dependent PplcA promoter is not acti-
vated in the presence of this mutant PrfA protein. These re-
sults suggest that region A of PrfA represents or at least in-
cludes the site of interaction between PrfA and RNAP.
In summary, we have presented a collection of mutations
that impair the function of PrfA. These mutations fall essen-
tially in three regions, which may represent functional domains
in this transcription factor. One should, however, keep in mind
that the described positive selection procedure for prfA mu-
tations is performed in B. subtilis, a heterologous bacterial
system which does not necessarily reproduce all the character-
istics and subtleties of PrfA-dependent regulation in L. mono-
cytogenes (3, 4). There is evidence that an additional factor(s)
is needed for this differential regulation by PrfA (1, 3, 11, 40,
52) and that this factor(s) may not be present in B. subtilis. In
addition, the culture conditions used (growth in BHI medium,
a rich medium) may not necessarily select for the interaction of
PrfA with such a factor(s), and hence possible regions in PrfA
essential for the interaction of PrfA with this factor(s), possibly
relevant to the differential regulation of PrfA-dependent
genes, are therefore not expected to be identified with this
selection procedure. Anyhow, the fact that we were able to
repeatedly identify with our selection system the same muta-
tions in several independent experiments provides at least cir-
cumstantial evidence that the three regions of PrfA identified
may represent critical functional domains. These are presum-
ably essential for binding to RNAP (region A), for binding to
its target DNA site (region B), and, possibly, for dimerization
(region C). The amino acids affected by the point mutations
may possibly play a key role in these functions. The PrfA
mutants described here, together with the elucidation of the
three-dimensional structure of the PrfA protein, may help in
FIG. 5. EMSA with 32P-labeled hly promoter DNA fragment and purified wild-type (WT) and mutant PrfA proteins M58I, R188I, and A218*
(see Fig. 3). (A) Formation of CIII complex with 200 or 400 ng of PrfA and target DNA. Arrowhead, position of the CIII complex. For a discussion
of the other bands in the control (C) and the EMSA with the wild-type and mutant PrfA proteins see text. (B) Formation of CI complex with
increasing amounts of partially purified RNAP (0.5, 1.0, and 2.0 ng of RNAPMEM) and 200 ng of PrfA per lane. CI, CII, and CIII, positions of
the various formed complexes (see text for details). Control (C) contains the 32P-labeled promoter probe but no PrfA protein. The band seen below
the CIII complexes and in the control is of unknown origin and was seen with this promoter probe but not with other preparations. Note again
the complete absence of the CIII complex in the EMSA with the mutant PrfA proteins R188I and A218*.
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the understanding of the structure and function of this listerial
key regulator.
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